2022: a tipping point in the treatment of mitral regurgitation patients - europcr 2022
Published 2 years ago • 2.7K plays • Length 1:22:38Download video MP4
Download video MP3
Similar videos
-
59:59
a new focus on mitral and tricuspid valve disease - europcr 2022
-
56:31
leading clinical evidence while disrupting the mitral paradigm with clip therapy - europcr2022
-
1:33:46
a patient-focused transcatheter portfolio of options to treat tricuspid regurgitation - europcr 2022
-
45:41
mitral replacement: expanding patient options, even mitral annular calcification! - europcr 2022
-
1:22:49
pascal precision system – mr tools and techniques symposium featuring patient cases | europcr 2022
-
8:35
expand your mitral portfolio with tendyne - europcr 2022
-
1:29:28
a case-based tailored approach to the treatment of mitral valve disease: the heart team ring
-
13:54
live case (toe): severe aortic regurgitation, bicuspid valve, ?infective endocarditis
-
5:30
highlife trans-septal mitral valve replacement (tsmvr) - clinical study update - europcr 2021
-
1:32:40
treating diverse mitral regurgitation anatomies: the power of versatility - europcr 2023
-
48:35
knocking mitral regurgitation down to improve outcomes: earlier is better, better late than never!
-
57:13
contemporary appraisal of functional mitral regurgitation in the transcatheter era
-
40:32
tavi for ar - addressing an unmet need with the jenavalve trilogy heart valve system - europcr 2022
-
57:29
transcatheter mitral valve replacement and repair: why do we need both - europcr 2021
-
54:59
double jeopardy: coronary disease in patients undergoing tavi - europcr 2022
-
0:58
"the leading cause of mitral regurgitation: uncovering the main culprit!"
-
5:34
learnings and perspectives from the coapt trial, 5-year follow-up - europcr 2023
-
17:00
highlife tsmvr - (not) only for the happy few? - europcr 2022
-
58:52
triclip therapy: here now, here to stay - europcr 2022